{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:57:02Z","timestamp":1793822222401,"version":"4.6.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"am","delay-in-days":353,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 AG034853"],"award-info":[{"award-number":["R01 AG034853"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004702","name":"Baxter International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004702","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1053\/j.ajkd.2021.03.026","type":"journal-article","created":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T21:55:51Z","timestamp":1622066151000},"page":"719-727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":176,"title":["The Promise of Tubule Biomarkers in Kidney Disease: A Review"],"prefix":"10.1053","volume":"78","author":[{"given":"Joachim H.","family":"Ix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Shlipak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.ajkd.2021.03.026_bib1","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"10.1053\/j.ajkd.2021.03.026_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(12)80312-X","article-title":"Tubulointerstitial changes as a major determinant in the progression of renal damage","volume":"20","author":"Nath","year":"1992","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.ajkd.2021.03.026_bib3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ki.1994.44","article-title":"Loss of glomerular function and tubulointerstitial fibrosis: cause or effect?","volume":"45","author":"Ong","year":"1994","journal-title":"Kidney Int"},{"issue":"9","key":"10.1053\/j.ajkd.2021.03.026_bib4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.7326\/0003-4819-152-9-201005040-00006","article-title":"The association between age and nephrosclerosis on renal biopsy among healthy adults","volume":"152","author":"Rule","year":"2010","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1053\/j.ajkd.2021.03.026_bib5","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/ndt\/16.6.1163","article-title":"Prognostic value of simple measurement of chronic damage in renal biopsy specimens","volume":"16","author":"Howie","year":"2001","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1053\/j.ajkd.2021.03.026_bib6","first-page":"349","article-title":"Benign nephrosclerosis: incidence, morphology and prognosis","volume":"55","author":"Takebayashi","year":"2001","journal-title":"Clin Nephrol"},{"issue":"10","key":"10.1053\/j.ajkd.2021.03.026_bib7","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.127456","article-title":"Urine TNF-\u03b1 and IL-9 for clinical diagnosis of acute interstitial nephritis","volume":"4","author":"Moledina","year":"2019","journal-title":"JCI Insight"},{"issue":"4","key":"10.1053\/j.ajkd.2021.03.026_bib8","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1053\/j.ajkd.2016.03.430","article-title":"HIV infection, tenofovir, and urine \u03b11-microglobulin: a cross-sectional analysis in the multicenter AIDS Cohort Study","volume":"68","author":"Jotwani","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.ajkd.2021.03.026_bib9","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ki.2013.154","article-title":"Numerous protein-bound solutes are cleared by the kidney with high efficiency","volume":"84","author":"Sirich","year":"2013","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2021.03.026_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12882-020-01721-z","article-title":"Furosemide stress test and interstitial fibrosis in kidney biopsies in chronic kidney disease","volume":"21","author":"Rivero","year":"2020","journal-title":"BMC Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2021.03.026_bib11","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1053\/j.ajkd.2016.08.022","article-title":"Urinary uromodulin and risk of urinary tract infections: the Cardiovascular Health Study","volume":"69","author":"Garimella","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2021.03.026_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1681\/ASN.2019030287","article-title":"A randomized trial comparing the safety, adherence, and pharmacodynamics profiles of two doses of sodium bicarbonate in CKD: the BASE pilot trial","volume":"31","author":"Raphael","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2021.03.026_bib13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2215\/CJN.03220314","article-title":"Association of urine \u03b11-microglobulin with kidney function decline and mortality in HIV-infected women","volume":"10","author":"Jotwani","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2021.03.026_bib14","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1053\/j.ajkd.2016.10.019","article-title":"Urine fibrosis markers and risk of allograft failure in kidney transplant recipients: a case-cohort ancillary study of the FAVORIT Trial","volume":"69","author":"Ix","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1053\/j.ajkd.2021.03.026_bib15","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1111\/ajt.14284","article-title":"Urinary markers of fibrosis and risk of cardiovascular events and death in kidney transplant recipients: the FAVORIT Trial","volume":"17","author":"Park","year":"2017","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1053\/j.ajkd.2021.03.026_bib16","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.2215\/CJN.12051115","article-title":"Association of urinary biomarkers of inflammation, injury, and fibrosis with renal function decline: the ACCORD Trial","volume":"11","author":"Nadkarni","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2021.03.026_bib17","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1681\/ASN.2016101101","article-title":"Plasma biomarkers and kidney function decline in early and established diabetic kidney disease","volume":"28","author":"Coca","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.ajkd.2021.03.026_bib18","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1159\/000509978","article-title":"Tubular biomarkers and chronic kidney disease progression in SPRINT participants","volume":"51","author":"Jotwani","year":"2020","journal-title":"Am J Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2021.03.026_bib19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2215\/CJN.02780319","article-title":"Urine markers of kidney tubule cell injury and kidney function decline in SPRINT Trial participants with CKD","volume":"15","author":"Malhotra","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"42","key":"10.1053\/j.ajkd.2021.03.026_bib20","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1093\/eurheartj\/ehz392","article-title":"Markers of kidney tubule function and risk of cardiovascular disease events and mortality in the SPRINT trial","volume":"40","author":"Garimella","year":"2019","journal-title":"Eur Heart J"},{"issue":"316","key":"10.1053\/j.ajkd.2021.03.026_bib21","doi-asserted-by":"crossref","first-page":"316ra193","DOI":"10.1126\/scitranslmed.aac7071","article-title":"Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker","volume":"7","author":"Ju","year":"2015","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1053\/j.ajkd.2021.03.026_bib22","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/ki.1996.94","article-title":"Expression of epidermal growth factor and its receptor in normal and diseased human kidney: an immunohistochemical and in situ hybridization study","volume":"49","author":"Gesualdo","year":"1996","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2021.03.026_bib23","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/sj.ki.5002621","article-title":"The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy","volume":"73","author":"Torres","year":"2008","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ajkd.2021.03.026_bib24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/ndt\/gfy314","article-title":"Associations of urinary epidermal growth factor and monocyte chemotactic protein-1 with kidney involvement in patients with diabetic kidney disease","volume":"35","author":"Wu","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2021.03.026_bib25","doi-asserted-by":"crossref","unstructured":"Norvik JV, Harskamp LR, Nair V, et\u00a0al. Urinary excretion of epidermal growth factor and rapid loss of kidney function. Nephrol Dial Transplant. Published online October 17, 2020. doi: 10.1093\/ndt\/gfaa208","DOI":"10.1093\/ndt\/gfaa208"},{"issue":"5","key":"10.1053\/j.ajkd.2021.03.026_bib26","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMoa1911481","article-title":"Soluble urokinase receptor and acute kidney injury","volume":"382","author":"Hayek","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1053\/j.ajkd.2021.03.026_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1681\/ASN.2020040487","article-title":"Association of multiple plasma biomarker concentrations with progression of prevalent diabetic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study","volume":"32","author":"Schrauben","year":"2021","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2021.03.026_bib28","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.kint.2019.03.024","article-title":"The SPRINT trial suggests that markers of tubule cell function in the urine associate with risk of subsequent acute kidney injury while injury markers elevate after the injury","volume":"96","author":"Bullen","year":"2019","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2021.03.026_bib29","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/QAD.0000000000002114","article-title":"Tenofovir disoproxil fumarate initiation and changes in urinary biomarker concentrations among HIV-infected men and women","volume":"33","author":"Zhang","year":"2019","journal-title":"AIDS"},{"issue":"9","key":"10.1053\/j.ajkd.2021.03.026_bib30","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2215\/CJN.01700218","article-title":"Association of urinary biomarkers of kidney injury with estimated GFR decline in HIV-infected individuals following tenofovir disoproxil fumarate initiation","volume":"13","author":"Ascher","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2021.03.026_bib31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/QAI.0000000000001654","article-title":"Pre-exposure prophylaxis with tenofovir disoproxil fumarate\/emtricitabine and kidney tubular dysfunction in HIV-uninfected individuals","volume":"78","author":"Jotwani","year":"2018","journal-title":"J\u00a0Acquir Immune Defic Syndr 1999"},{"issue":"9","key":"10.1053\/j.ajkd.2021.03.026_bib32","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1681\/ASN.2017020148","article-title":"Effects of intensive BP control in CKD","volume":"28","author":"Cheung","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2021.03.026_bib33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/j.ajkd.2018.07.015","article-title":"Effects of intensive blood pressure lowering on kidney tubule injury in CKD: a longitudinal subgroup analysis in SPRINT","volume":"73","author":"Malhotra","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1053\/j.ajkd.2021.03.026_bib34","doi-asserted-by":"crossref","first-page":"610","DOI":"10.7326\/M18-1037","article-title":"Kidney damage biomarkers and incident chronic kidney disease during blood pressure reduction: a case-control study","volume":"169","author":"Zhang","year":"2018","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1053\/j.ajkd.2021.03.026_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1053\/j.ajkd.2018.07.016","article-title":"Effect of intensive blood pressure lowering on kidney tubule injury: findings from the ACCORD Trial study participants","volume":"73","author":"Nadkarni","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2021.03.026_bib36","doi-asserted-by":"crossref","unstructured":"Moledina DG, Wilson FP, Kukova L, et\u00a0al. Urine interleukin-9 and tumor necrosis factor-\u03b1 for prognosis of human acute interstitial nephritis. Nephrol Dial Transplant. Published online October 28, 2020. doi: 10.1093\/ndt\/gfaa169","DOI":"10.1093\/ndt\/gfaa169"},{"issue":"5","key":"10.1053\/j.ajkd.2021.03.026_bib37","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1681\/ASN.2019070723","article-title":"Plasma biomarkers of tubular injury and inflammation are associated with CKD progression in children","volume":"31","author":"Greenberg","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2021.03.026_bib38","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.119.13339","article-title":"Distinct dimensions of kidney health and risk of cardiovascular disease, heart failure, and mortality","volume":"74","author":"Lee","year":"2019","journal-title":"Hypertension"},{"issue":"1","key":"10.1053\/j.ajkd.2021.03.026_bib39","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.kint.2016.09.003","article-title":"Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression","volume":"91","author":"Hsu","year":"2017","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2021.03.026_bib40","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1681\/ASN.2019080811","article-title":"Kidney clearance of secretory solutes is associated with progression of CKD: the CRIC Study","volume":"31","author":"Chen","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2021.03.026_bib41","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S2213-8587(18)30314-0","article-title":"Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials","volume":"7","author":"Heerspink","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1053\/j.ajkd.2021.03.026_bib42","doi-asserted-by":"crossref","first-page":"384","DOI":"10.2215\/CJN.15260920","article-title":"Kidney, cardiovascular, and safety outcomes of canagliflozin according to baseline albuminuria: a CREDENCE secondary analysis","volume":"16","author":"Jardine","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2021.03.026_bib43","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/QAD.0000000000002456","article-title":"HIV preexposure prophylaxis with tenofovir disoproxil fumarate\/emtricitabine and changes in kidney function and tubular health","volume":"34","author":"Ascher","year":"2020","journal-title":"AIDS"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638621006351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638621006351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:26:41Z","timestamp":1777541201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638621006351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0272638621006351"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2021.03.026","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Promise of Tubule Biomarkers in Kidney Disease: A Review","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2021.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc. This is a US Government Work. There are no restrictions on its use.","name":"copyright","label":"Copyright"}]}}